Biemamides and related scaffolds as inhibitors of transforming growth factor-beta signaling
Abstract:
The present technology provides an isolated compound of Formula I, compositions including such compounds, methods of inhibiting TGF-β signaling and/or TGF-β induced epithelial mesenchymal transitions (EMT), and treating certain cancers involving TGF-β signaling and/or EMT.
Information query
Patent Agency Ranking
0/0